The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26
Open accessAbstract
A subset of prolyl oligopeptidases, including dipeptidyl-peptidase IV (DPP IV or CD26, EC 3.4.14.5), specifically cleave off N-terminal dipeptides from substrates having proline or alanine in amino acid position 2. This enzyme activity has been implicated in the regulation of the biological activity of multiple hormones and chemokines, including the insulinotropic peptides glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Targeted inactivation of the CD26 gene yielded healthy mice that have normal blood glucose levels in the fasted state, but reduced glycemic excursion after a glucose challenge. Levels of glucose-stimulated circulating insulin and the intact insulinotropic form of GLP-1 are increased in CD26−/−mice. A pharmacological inhibitor of DPP IV enzymatic activity improved glucose tolerance in wild-type, but not in CD26−/−, mice. This inhibitor also improved glucose tolerance in GLP-1 receptor−/−mice, indicating that CD26 contributes to blood glucose regulation by controlling the activity of GLP-1 as well as additional substrates. These data reveal a critical role for CD26 in physiological glucose homeostasis, and establish it as a potential target for therapy in type II diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides
Mentlein, R. (1999) · Regulatory Peptides · doi:10.1016/s0167-0115(99)00089-0 · Cited by 1,272
MENTLEIN, R., GALLWITZ, B., & SCHMIDT, W. E. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17986.x · Cited by 1,161
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124
Deacon, C. F., Nauck, M. A., Toft-Nielsen, M., Pridal, L., Willms, B., & Holst, J. J. (1995) · Diabetes · doi:10.2337/diab.44.9.1126 · Cited by 878
Scrocchi, L. A., Brown, T. J., Maclusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., & Drucker, D. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1254 · Cited by 793
Self-citation[2] Families of serine peptidases
Rawlings, N. D., & Barrett, A. J. (1994) · Methods in Enzymology · doi:10.1016/0076-6879(94)44004-2 · Cited by 629
Drucker, D. J. (1998) · Diabetes · doi:10.2337/diab.47.2.159 · Cited by 601
Self-citationDirect Association of Adenosine Deaminase with a T Cell Activation Antigen, CD26
Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., & Morimoto, C. (1993) · Science · doi:10.1126/science.8101391 · Cited by 507
Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes.
Holst, J. J., & Deacon, C. F. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1663 · Cited by 487
Miyawaki, K., Yamada, Y., Yano, H., Niwa, H., Ban, N., Ihara, Y., Kubota, A., Fujimoto, S., Kajikawa, M., Kuroe, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14843 · Cited by 454
CD26, let it cut or cut it down
De Meester, I., Korom, S., Van Damme, J., & Scharpé, S. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01486-3 · Cited by 451
The structure and function of CD26 in the T‐cell immune response
Morimoto, C., & Schlossman, S. F. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01571.x · Cited by 421
Deacon, C. F., Hughes, T. E., & Holst, J. J. (1998) · Diabetes · doi:10.2337/diabetes.47.5.764 · Cited by 321
Pederson, R. A., White, H. A., Schlenzig, D., Pauly, R. P., McIntosh, C. H. S., & Demuth, H.-U. (1998) · Diabetes · doi:10.2337/diab.47.8.1253 · Cited by 267
Balkan, B., Kwasnik, L., Miserendino, R., Holst, J. J., & Li, X. (1999) · Diabetologia · doi:10.1007/s001250051445 · Cited by 209
Establishment of a germ-line competent C57BL/6 embryonic stem cell line
Ledermann, B., & Bürki, K. (1991) · Experimental Cell Research · doi:10.1016/0014-4827(91)90430-3 · Cited by 199
A Role for Dipeptidyl Peptidase IV in Suppressing the Malignant Phenotype of Melanocytic Cells
Wesley, U. V., Albino, A. P., Tiwari, S., & Houghton, A. N. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.3.311 · Cited by 190
Pederson, R. A., Satkunarajah, M., McIntosh, C. H., Scrocchi, L. A., Flamez, D., Schuit, F., Drucker, D. J., & Wheeler, M. B. (1998) · Diabetes · doi:10.2337/diabetes.47.7.1046 · Cited by 167
Self-citationScrocchi, L. A., Marshall, B. A., Cook, S., Brubaker, P. L., & Drucker, D. J. (1998) · Diabetes · doi:10.2337/diabetes.47.4.632 · Cited by 125
Self-citationAbbott, C. A., McCaughan, G. W., & Gorrell, M. D. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01166-7 · Cited by 120
Targeted Disruption of Mouse Fibroblast Activation Protein
Niedermeyer, J., Kriz, M., Hilberg, F., Garin‐Chesa, P., Bamberger, U., Lenter, M., Park, J., Viertel, B., Püschner, H., Mauz, M., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.1089-1094.2000 · Cited by 119
Tavares, W., Drucker, D. J., & Brubaker, P. L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.1.e134 · Cited by 119
Self-citationSCHÖN, E., Born, I., Demuth, H., Faust, J., Neubert, K., Steinmetzer, T., Barth, A., & ANSORGE, S. (1991) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1991.372.1.305 · Cited by 114
Pauly, R. P., Demuth, H., Rosche, F., Schmidt, J., White, H. A., Lynn, F. C., McIntosh, C. H. S., & Pederson, R. A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90090-2 · Cited by 102
Marguet, D., Bernard, A., Vivier, I., Darmoul, D., Naquet, P., & Pierres, M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45862-0 · Cited by 93
Self-citationChiravuri, M., Schmitz, T. L., Yardley, K., Underwood, R., Dayal, Y., & Huber, B. T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3092 · Cited by 88
David, F., Bernard, A., Pierres, M., & Marguet, D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85329-2 · Cited by 70
Self-citationMouse fibroblast‐activation protein
Niedermeyer, J., Enenkel, B., Park, J. E., Lenter, M., Rettig, W. J., Damm, K., & Schnapp, A. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540650.x · Cited by 69
Jacotot, E. D., Callebaut, C., Blanco, J., Krust, B., Neubert, K., Barth, A., & Hovanessian, A. G. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0248u.x · Cited by 49
The enteroinsular axis in dipeptidyl peptidase IV-negative rats
Pederson, R. A., Kieffer, T. J., Pauly, R. P., Kofod, H., Kwong, J., & McIntosh, C. H. S. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90112-2 · Cited by 49
Cloning and Characterization of a Novel Peptidase from Rat and Human Ileum
Shneider, B. L., Thevananther, S., Moyer, M. S., Walters, H. C., Rinaldo, P., Devarajan, P., Sun, A. Q., Dawson, P. A., & Ananthanarayanan, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.31006 · Cited by 33
Structure of the mouse dipeptidyl peptidase IV (CD26) gene
Bernard, A., Mattéi, M., Pierres, M., & Marguet, D. (1994) · Biochemistry · doi:10.1021/bi00254a032 · Cited by 33
Self-citationThe role of growth hormone and glucocorticoid in glucose handling in vivo
Johansen, T., Deckert, M., Mandrup-Poulsen, T. R., & Malmlöf, K. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1620087 · Cited by 15
Cited by
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Self-citationBiology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
Self-citationThe biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Self-citationTargeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
New drug targets for type 2 diabetes and the metabolic syndrome
Moller, D. E. (2001) · Nature · doi:10.1038/414821a · Cited by 1,008
Metadata
- Authors
- Marguet, D., Baggio, L., Kobayashi, T., Bernard, A.-M., Pierres, M., Nielsen, P. F., Ribel, U., Watanabe, T., Drucker, D. J., & Wagtmann, N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-05-23
- Volume
- 97
- Issue
- 12
- Pages
- 6874-6879
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1979916078
- Cited by
- 538
- References
- 33
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.